Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-054221

Chief Medical Officer sold 6,250 shares at an average $49.20 ($307,518)

  • Chief Medical Officer acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BALDO LANCE · Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-10-06 Exercise or conversion : show line 1 in the form +6,250 $7.80 $48,750 6,250 D
2020-10-06 Sale : show line 2 in the form −4,236 $48.90 $207,140 2,014 D
2020-10-06 Sale : show line 3 in the form −2,014 $49.84 $100,378 0 D
Open-market sales · 6,250 sh · avg $49.20 · $307,518

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-10-06 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −6,250 393,750 D
Loading xslF345X03/doc4.xml…